Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
PFOCUSNSE
SAGILITYNSE
SYNGENENSE
HORIZONINDNSE
INDGNNSE
IGILNSE
NESCONSE
SPARCNSE
LEAPINDNSE
SMARTWORKSNSE
Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 11% | 5% | 3% |
| - | -5% | -12% | -36% |
| 5% | -10% | -21% | -41% |
| 15% | 12% | 10% | 7% |
Peer Comparison
Symbol
PFOCUS
SAGILITY
SYNGENE
HORIZONIND
INDGN
IGIL
NESCO
SPARC
LEAPIND
SMARTWORKS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 318.75 | ₹26186 Cr | 226.57 | -0.53 | 10.52 | ₹219 Cr |
| 45 | ₹21520 Cr | 21.67 | 0.46 | 3.18 | ₹925 Cr |
| 380.35 | ₹15404 Cr | 69.7 | -0.22 | 16.72 | ₹317 Cr |
| 51.81 | ₹15375 Cr | — | -0.04 | 0.24 | -₹198 Cr |
| 594.1 | ₹14413 Cr | 35.95 | 4.83 | 22.82 | ₹401 Cr |
| 325.25 | ₹14356 Cr | 23.55 | 3.84 | 15.26 | ₹711 Cr |
| 1,078 | ₹7600 Cr | 18.25 | 14.19 | 66.2 | ₹413 Cr |
| 203.98 | ₹6679 Cr | 4.22 | -0.64 | 49.12 | ₹1553 Cr |
| 143.09 | ₹6540 Cr | 104.9 | 2.05 | 6.05 | ₹62 Cr |
| 538.5 | ₹6209 Cr | 222.77 | 1.15 | 81.21 | ₹11 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — |
| ₹403 Cr | ₹403 Cr | ₹402 Cr | ₹401 Cr | ₹401 Cr | ₹400 Cr | ₹400 Cr | ₹200 Cr | ₹200 Cr |
| ₹94 Cr | ₹79 Cr | ₹69 Cr | ₹65 Cr | ₹88 Cr | ₹77 Cr | ₹39 Cr | ₹28 Cr | ₹28 Cr |
| ₹4342 Cr | ₹4245 Cr | ₹3787 Cr | ₹3151 Cr | ₹2809 Cr | ₹2344 Cr | ₹1737 Cr | ₹1740 Cr | ₹1492 Cr |
| ₹4342 Cr | ₹4245 Cr | ₹3787 Cr | ₹3151 Cr | ₹2809 Cr | ₹2344 Cr | ₹1737 Cr | ₹1740 Cr | ₹1492 Cr |
| ₹4839 Cr | ₹4727 Cr | ₹4258 Cr | ₹3618 Cr | ₹3298 Cr | ₹2821 Cr | ₹2176 Cr | ₹1968 Cr | ₹1720 Cr |
| ₹0 | ₹0 | ₹100 Cr | ₹489 Cr | ₹532 Cr | ₹512 Cr | ₹0 | ₹347 Cr | ₹569 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹17 Cr |
| -₹101 Cr | -₹30 Cr | -₹41 Cr | -₹70 Cr | -₹66 Cr | -₹89 Cr | -₹123 Cr | -₹92 Cr | -₹72 Cr |
| ₹645 Cr | ₹629 Cr | ₹609 Cr | ₹492 Cr | ₹471 Cr | ₹364 Cr | ₹407 Cr | ₹223 Cr | ₹71 Cr |
| ₹18 Cr | ₹43 Cr | ₹41 Cr | ₹44 Cr | ₹34 Cr | ₹52 Cr | ₹41 Cr | ₹37 Cr | ₹29 Cr |
| ₹563 Cr | ₹643 Cr | ₹709 Cr | ₹955 Cr | ₹972 Cr | ₹840 Cr | ₹325 Cr | ₹515 Cr | ₹613 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹348 Cr | ₹352 Cr | ₹256 Cr | ₹258 Cr | ₹233 Cr | ₹242 Cr | ₹222 Cr | ₹224 Cr | ₹204 Cr |
| ₹1053 Cr | ₹845 Cr | ₹727 Cr | ₹778 Cr | ₹656 Cr | ₹572 Cr | ₹955 Cr | ₹678 Cr | ₹476 Cr |
| ₹9 Cr | ₹120 Cr | ₹42 Cr | ₹86 Cr | ₹258 Cr | ₹260 Cr | ₹309 Cr | ₹191 Cr | ₹78 Cr |
| ₹142 Cr | ₹80 Cr | ₹120 Cr | ₹66 Cr | ₹82 Cr | ₹60 Cr | ₹53 Cr | ₹37 Cr | ₹26 Cr |
| ₹1552 Cr | ₹1396 Cr | ₹1144 Cr | ₹1188 Cr | ₹1229 Cr | ₹1133 Cr | ₹1539 Cr | ₹1129 Cr | ₹784 Cr |
| ₹6954 Cr | ₹6766 Cr | ₹6111 Cr | ₹5761 Cr | ₹5498 Cr | ₹4794 Cr | ₹4040 Cr | ₹3612 Cr | ₹3117 Cr |
| ₹537 Cr | ₹634 Cr | ₹637 Cr | ₹622 Cr | ₹548 Cr | ₹430 Cr | ₹425 Cr | ₹336 Cr | ₹239 Cr |
| ₹9 Cr | ₹120 Cr | ₹142 Cr | ₹575 Cr | ₹790 Cr | ₹772 Cr | ₹686 Cr | ₹797 Cr | ₹787 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹5821 Cr | ₹5229 Cr | ₹4946 Cr | ₹4481 Cr | ₹3883 Cr | ₹3404 Cr | ₹2967 Cr | ₹2121 Cr | ₹1661 Cr |
| ₹2852 Cr | ₹2462 Cr | ₹2137 Cr | ₹1863 Cr | ₹1528 Cr | ₹1241 Cr | ₹984 Cr | ₹784 Cr | ₹630 Cr |
| ₹2969 Cr | ₹2767 Cr | ₹2809 Cr | ₹2619 Cr | ₹2354 Cr | ₹2163 Cr | ₹1984 Cr | ₹1337 Cr | ₹1030 Cr |
| ₹1040 Cr | ₹1261 Cr | ₹837 Cr | ₹177 Cr | ₹346 Cr | ₹237 Cr | ₹234 Cr | ₹274 Cr | ₹155 Cr |
| ₹285 Cr | ₹36 Cr | ₹35 Cr | ₹94 Cr | ₹270 Cr | ₹279 Cr | ₹38 Cr | ₹0 | ₹0 |
| ₹285 Cr | ₹36 Cr | ₹35 Cr | ₹94 Cr | ₹270 Cr | ₹279 Cr | ₹38 Cr | ₹0 | ₹0 |
| ₹168 Cr | ₹196 Cr | ₹240 Cr | ₹181 Cr | ₹151 Cr | ₹115 Cr | ₹108 Cr | ₹122 Cr | ₹95 Cr |
| ₹313 Cr | ₹179 Cr | ₹190 Cr | ₹217 Cr | ₹132 Cr | ₹156 Cr | ₹28 Cr | ₹76 Cr | ₹116 Cr |
| ₹4811 Cr | ₹4479 Cr | ₹4152 Cr | ₹3336 Cr | ₹3292 Cr | ₹2987 Cr | ₹2428 Cr | ₹1848 Cr | ₹1396 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹456 Cr | ₹611 Cr | ₹513 Cr | ₹824 Cr | ₹764 Cr | ₹423 Cr | ₹738 Cr | ₹716 Cr | ₹158 Cr |
| ₹141 Cr | ₹156 Cr | ₹239 Cr | ₹333 Cr | ₹179 Cr | ₹60 Cr | ₹25 Cr | ₹43 Cr | ₹86 Cr |
| ₹509 Cr | ₹527 Cr | ₹442 Cr | ₹529 Cr | ₹508 Cr | ₹476 Cr | ₹398 Cr | ₹339 Cr | ₹267 Cr |
| ₹833 Cr | ₹787 Cr | ₹564 Cr | ₹532 Cr | ₹518 Cr | ₹643 Cr | ₹282 Cr | ₹437 Cr | ₹967 Cr |
| ₹74 Cr | ₹103 Cr | ₹106 Cr | ₹132 Cr | ₹157 Cr | ₹174 Cr | ₹101 Cr | ₹200 Cr | ₹181 Cr |
| ₹129 Cr | ₹104 Cr | ₹96 Cr | ₹75 Cr | ₹80 Cr | ₹32 Cr | ₹69 Cr | ₹29 Cr | ₹62 Cr |
| ₹2143 Cr | ₹2287 Cr | ₹1959 Cr | ₹2425 Cr | ₹2206 Cr | ₹1807 Cr | ₹1613 Cr | ₹1764 Cr | ₹1720 Cr |
| ₹591 Cr | ₹891 Cr | ₹815 Cr | ₹1237 Cr | ₹977 Cr | ₹674 Cr | ₹73 Cr | ₹636 Cr | ₹937 Cr |
| ₹6954 Cr | ₹6766 Cr | ₹6111 Cr | ₹5761 Cr | ₹5498 Cr | ₹4794 Cr | ₹4040 Cr | ₹3612 Cr | ₹3117 Cr |
| ₹118 | ₹115 | ₹104 | ₹89 | ₹80 | ₹69 | ₹53 | ₹97 | ₹85 |
| ₹118 | ₹115 | ₹104 | ₹89 | ₹80 | ₹69 | ₹53 | ₹49 | ₹42 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| ₹411 Cr | ₹660 Cr | ₹621 Cr | ₹594 Cr | ₹484 Cr | ₹469 Cr | ₹517 Cr | ₹415 Cr | ₹373 Cr |
| ₹516 Cr | ₹471 Cr | ₹390 Cr | ₹385 Cr | ₹382 Cr | ₹279 Cr | ₹223 Cr | ₹129 Cr | ₹181 Cr |
| ₹58 Cr | ₹152 Cr | ₹156 Cr | -₹18 Cr | -₹180 Cr | ₹37 Cr | ₹44 Cr | ₹182 Cr | -₹27 Cr |
| ₹985 Cr | ₹1283 Cr | ₹1167 Cr | ₹960 Cr | ₹686 Cr | ₹785 Cr | ₹784 Cr | ₹727 Cr | ₹527 Cr |
| ₹915 Cr | ₹1168 Cr | ₹1042 Cr | ₹824 Cr | ₹581 Cr | ₹701 Cr | ₹677 Cr | ₹630 Cr | ₹446 Cr |
| -₹860 Cr | -₹745 Cr | -₹496 Cr | -₹656 Cr | -₹612 Cr | -₹628 Cr | -₹428 Cr | -₹647 Cr | -₹349 Cr |
| -₹215 Cr | -₹142 Cr | -₹551 Cr | -₹343 Cr | -₹31 Cr | ₹58 Cr | -₹226 Cr | -₹72 Cr | -₹79 Cr |
| -₹160 Cr | ₹281 Cr | -₹5 Cr | -₹175 Cr | -₹62 Cr | ₹131 Cr | ₹23 Cr | -₹89 Cr | ₹18 Cr |
| ₹367 Cr | ₹86 Cr | ₹90 Cr | ₹262 Cr | ₹323 Cr | ₹193 Cr | ₹165 Cr | ₹253 Cr | ₹235 Cr |
| ₹22 Cr | ₹30 L | ₹1 Cr | ₹3 Cr | ₹70 L | -₹80 L | ₹5 Cr | ₹1 Cr | ₹0 |
| ₹229 Cr | ₹367 Cr | ₹86 Cr | ₹90 Cr | ₹262 Cr | ₹323 Cr | ₹193 Cr | ₹165 Cr | ₹253 Cr |
Fundamental Ratios
Consolidated
Standalone
Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 4 out of 9 oscillators
RSI
42.25Sell
STOCH %K
46.67Neutral
MACD Level(12,26)
-6.86Sell
Ultimate Oscillator
53.37Buy
Aroon Oscillator
-92.00Sell
BOP
0.05Buy
CCI
-53.55Neutral
Williams %R
-53.33Neutral
Momentum
-20.45Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 8 out of 9 moving averages
EMA 9
381.41Sell
SMA 9
379.52Buy
EMA 21
387.46Sell
SMA 21
389.98Sell
EMA 50
399.49Sell
SMA 50
399.03Sell
EMA 200
463.23Sell
SMA 200
462.67Sell
WMA 20
383.54Sell
Pivot
Pivot
Classic
Resistance 5
428.08
Resistance 4
416.38
Resistance 3
404.68
Resistance 2
392.98
Resistance 1
387.42
Pivot
381.28
Support 1
375.72
Support 2
369.58
Support 3
357.88
Support 4
346.18
Support 5
334.48
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 52.59% | 52.68% | 52.68% | 52.68% | 52.68% | 52.74% |
| 11.82% | 13.91% | 14.96% | 16.31% | 16.50% | 19.47% |
| 2.23% | 2.26% | 3.12% | 3.40% | 3.35% | 3.64% |
| 25.78% | 24.18% | 22.71% | 21.22% | 20.70% | 17.86% |
| 7.58% | 6.97% | 6.53% | 6.39% | 6.77% | 6.29% |
Bulk & block deals
Name
Microcurves Trading Private Limited
Nk Securities Research Private Limited
Microcurves Trading Private Limited
Nk Securities Research Private Limited
Biocon Limited
Government Of Singapore
Biocon Limited
Government Of Singapore
Monetary Authority Of Singapore
Motilal Oswal Mutual Fund
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 30 Apr 2026 | Purchase | 133.31 Cr | ₹481.90 | 27.66 L | Bulk | 0.685286 | NSE |
| 30 Apr 2026 | Purchase | 105.09 Cr | ₹486.40 | 21.61 L | Bulk | 0.53524 | NSE |
| 30 Apr 2026 | Sell | 133.34 Cr | ₹482.02 | 27.66 L | Bulk | 0.685286 | NSE |
| 30 Apr 2026 | Sell | 105.14 Cr | ₹486.62 | 21.61 L | Bulk | 0.53524 | NSE |
| 10 Dec 2024 | Sell | 686.14 Cr | ₹857.68 | 80 L | Bulk | 1.981821 | BSE |
| 01 Feb 2023 | Purchase | 884.76 Cr | ₹560 | 1.58 Cr | Bulk | 3.913899 | BSE |
| 01 Feb 2023 | Sell | 2,240 Cr | ₹560 | 4 Cr | Bulk | 9.909106 | BSE |
| 01 Feb 2023 | Purchase | 884.76 Cr | ₹560 | 1.58 Cr | Block | 3.913899 | BSE |
| 01 Feb 2023 | Purchase | 190.44 Cr | ₹560 | 34.01 L | Block | 0.842472 | BSE |
| 01 Feb 2023 | Purchase | 95.20 Cr | ₹560 | 17 L | Block | 0.421137 | BSE |
Insider trading & SAST
Client name
Mirae Asset Mutual Fund
Nippon India Mutual Fund
Dsp Trustee Pvt Ltd
Nippon India Mutual Fund
Mirae Asset Mutual Fund
Mirae Asset Mutual Fund
Anjan Chakrabarti
Biocon Ltd & Others
Biocon Limited
Mayank Verma
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 Aug 2026 | Other | Disposal | 0.21 | 0.81 | 0 | — | 8.61 L | 21 Jul 2026 | Market | 32,60,491 | SAST | 29(2) | — |
| 26 May 2026 | Other | Acquisition | 0.39 | 7.11 | 0 | — | 16 L | 16 Feb 2026 - 10 Apr 2026 | Market | 2,86,76,571 | SAST | 29(2) | — |
| 26 May 2026 | Other | Acquisition | 0.24 | 5.03 | 0 | — | 9.93 L | 07 Apr 2026 | Market | 2,02,86,226 | SAST | 29(1) | — |
| 27 Feb 2026 | Other | Acquisition | 2.61 | 5.08 | 0 | — | 5.75 L | 29 Jul 2025 - 13 Feb 2026 | Market | 2,04,70,775 | SAST | 29(1) | — |
| 15 Oct 2025 | Other | Disposal | 0.16 | 2.95 | 0 | — | 6.67 L | 02 Sep 2025 | Market | 1,19,07,883 | SAST | 29(2) | — |
| 13 May 2025 | Other | Acquisition | 0.09 | 5.07 | 0 | — | 3.62 L | 08 May 2025 | Market | 2,03,98,585 | SAST | 29(1) | — |
| 27 Dec 2024 | Designated Person | Disposal | 0.001538 | 0.01 | 52.65 L | ₹850.59 | 6.19 K | 27 Dec 2024 | Market Sale | 25,000 | Insider Trading | — | Equity Shares |
| 17 Dec 2024 | Promoter | Disposal | 1.99 | 52.46 | 0 | — | 80 L | 10 Dec 2024 | Market | 21,11,85,608 | SAST | 29(2) | — |
| 11 Dec 2024 | Promoter | Disposal | 1.987395 | 52.46 | 686.14 Cr | ₹857.68 | 80 L | 10 Dec 2024 | Block Deal | 21,11,85,608 | Insider Trading | — | Equity Shares |
| 28 Nov 2024 | Designated Person | Disposal | 0.000373 | 0 | 13.70 L | ₹913.17 | 1.50 K | 26 Nov 2024 | Market Sale | 1,250 | Insider Trading | — | Equity Shares |
Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
Syngene International is a contract research, development, and manufacturing services company that offers a broad range of scientific services from the earliest stages of discovery to commercial supplies. This positions
Corporate Actions
Date
Type
Details
Company details
Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Syngene International Share Price
380.35-1.50 (-0.39%)
-40.91% past 1 Year
News
Syngene International to host analyst and investor meet on September 24
Equity
SYNGENE
Syngene International to host analyst and investor meet on September 17
Equity
SYNGENE
Goldman Sachs maintains Accumulate on Syngene with Rs 450 target price
Equity
SYNGENE
Syngene International to host analyst and investor meet on August 31
Equity
SYNGENE
Syngene says Bayview Facility will remain uncapitalized in FY27
Equity
SYNGENE
Syngene International expects margin improvement from H2 FY27 revenue and cost controls
Equity
SYNGENE
Syngene International guides for profitable, sustainable growth from FY28 onwards
Equity
SYNGENE
Syngene International revises FY27 guidance after Zoetis offtake halt, client attrition
Equity
SYNGENE
Syngene International guides single-digit FY27 revenue decline, margins mid-20s
Equity
SYNGENE
Syngene guides FY27 mid-20 percent EBITDA margin on cost optimisation focus
Equity
SYNGENE
Syngene International to double down on CDMO business in FY27
Equity
SYNGENE
Macquarie maintains Outperform on Syngene, sees H2FY27 business recovery
Equity
SYNGENE
Syngene International reports exceptional item of Rs 13.50 crores in results
Equity
SYNGENE
Syngene International Q1 FY earnings show sharp EBITDA and margin decline YoY
Equity
SYNGENE
Syngene International reports sharp year-on-year revenue decline in Q1 results
Equity
SYNGENE
Syngene International posts Q1 net loss versus prior year profit, earnings miss
Equity
SYNGENE
Syngene International to host Q1 earnings call on July 30 at 9 am
Equity
SYNGENE
Syngene promoter Kiran Mazumdar-Shaw signals confidence in business turnaround outlook
Equity
SYNGENE
Syngene International appoints Siddharth Mittal as new MD and CEO
Equity
SYNGENE
Syngene International informs about newspaper advertisements
Equity
SYNGENE

